title: Predictive factors for false negative sentinel lymph node in melanoma patients.
abstract: BACKGROUND
  Sentinel lymph node biopsy (SLNB) represents a useful tool for staging melanoma patients. However false-negative SLNB are reported in the literature.
  
  
  OBJECTIVE
  The aim of our study is to identify predictive factors for false-negative SLNB in melanoma patients.
  
  
  METHODS
  We conducted a retrospective analysis on 316 melanoma patients who underwent SLNB and were followed up at the Department of Dermatology and Plastic Surgery of University of Rome "Sapienza" from March 1994 to June 2008.
  
  
  RESULTS
  In our patients, SLNB was positive in 35 cases (11.07%) whereas it was negative in 281 cases (88.93%); 12/316 patients (3.8%) had positive SLNB and positive therapeutic lymph node dissection (TLND); 23/316 (7.28%) patients had positive SLNB and negative TLND; 266/316 (84.18%) patients had negative SLNB but without subsequent metastases in the SLN site; 15/316 (4.74%) patients had negative SLNB, but with subsequent metastases in the same SLN site (false-negative patients). Among the different prognostic factors, only ulceration was the main predictive factor for false-negative SLNB, according to statistical analysis (p=.0420).
  
  
  CONCLUSIONS
  Our data confirm that SLNB is a useful technique for staging melanoma patients. However, in patients with negative SLNB, a closer follow-up is recommended when ulceration is present. The authors have indicated no significant interest with commercial supporters.
authors.affiliation: Department of Dermatology and Plastic Surgery, University of Rome Sapienza, Viale del Policlinico, Rome, Italy. ilcapo75@gmx.net
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Panasiti
authors.forename: Valeria
authors.initials: V
authors.lastname: Devirgiliis
authors.forename: Michela
authors.initials: M
authors.lastname: Curzio
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Roberti
authors.forename: Silvia
authors.initials: S
authors.lastname: Gobbi
authors.forename: Mariarita
authors.initials: M
authors.lastname: Rossi
authors.forename: Ugo
authors.initials: U
authors.lastname: Bottoni
authors.forename: Rita
authors.initials: R
authors.lastname: Clerico
authors.forename: Nicolo
authors.initials: N
authors.lastname: Scuderi
authors.forename: Stefano
authors.initials: S
authors.lastname: Calvieri
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018572:Disease-Free Survival; D005188:False Negative Reactions; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016015:Logistic Models; D008197:Lymph Node Excision; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis; D008297:Male; D008545:Melanoma / Q000401:mortality / Q000473:pathology / Q000556:secondary*; D008875:Middle Aged; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D012189:Retrospective Studies; D021701:Sentinel Lymph Node Biopsy / Q000592:standards*; D012878:Skin Neoplasms / Q000401:mortality / Q000473:pathology*; D016019:Survival Analysis; D015996:Survival Rate; D055815:Young Adult